Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice
about
The stress polarity pathway: AMPK 'GIV'-es protection against metabolic insults.AMP-activated protein kinase: a therapeutic target in intestinal diseases.Metformin protects against intestinal barrier dysfunction via AMPKα1-dependent inhibition of JNK signalling activation.AMPK improves gut epithelial differentiation and barrier function via regulating Cdx2 expression.
P2860
Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice
@ast
Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice
@en
Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice
@nl
type
label
Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice
@ast
Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice
@en
Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice
@nl
prefLabel
Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice
@ast
Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice
@en
Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice
@nl
P2093
P2860
P1433
P1476
Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice
@en
P2093
Hanying Zhang
Mei-Jun Zhu
Yansong Xue
P2860
P304
P356
10.1371/JOURNAL.PONE.0168670
P407
P50
P577
2016-01-01T00:00:00Z